S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
NASDAQ:XBIT

XBiotech (XBIT) Stock Price, News & Analysis

$9.31
-0.19 (-2.00%)
(As of 10:43 AM ET)
Today's Range
$9.12
$9.52
50-Day Range
$5.42
$9.89
52-Week Range
$3.05
$9.96
Volume
12,527 shs
Average Volume
59,166 shs
Market Capitalization
$283.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
XBIT stock logo

About XBiotech Stock (NASDAQ:XBIT)

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

XBIT Stock Price History

XBIT Stock News Headlines

SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
XBIT Mar 2024 5.000 call
XBiotech Inc XBIT
SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
See More Headlines
Receive XBIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XBiotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/15/2024
Today
4/12/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:XBIT
Employees
82
Year Founded
N/A

Profitability

Net Income
$-24,560,000.00
Pretax Margin
-7,401.67%

Debt

Sales & Book Value

Annual Sales
$4.01 million
Book Value
$7.19 per share

Miscellaneous

Free Float
21,803,000
Market Cap
$289.28 million
Optionable
Optionable
Beta
1.45
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

XBIT Stock Analysis - Frequently Asked Questions

How have XBIT shares performed in 2024?

XBiotech's stock was trading at $4.00 at the beginning of 2024. Since then, XBIT stock has increased by 132.8% and is now trading at $9.31.
View the best growth stocks for 2024 here
.

When is XBiotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our XBIT earnings forecast
.

How were XBiotech's earnings last quarter?

XBiotech Inc. (NASDAQ:XBIT) posted its earnings results on Friday, March, 15th. The biopharmaceutical company reported ($0.16) EPS for the quarter.

What is John Simard's approval rating as XBiotech's CEO?

20 employees have rated XBiotech Chief Executive Officer John Simard on Glassdoor.com. John Simard has an approval rating of 58% among the company's employees. This puts John Simard in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of XBiotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other XBiotech investors own include Micron Technology (MU), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Intel (INTC), Pfizer (PFE) and Block (SQ).

When did XBiotech IPO?

XBiotech (XBIT) raised $76 million in an IPO on Wednesday, April 15th 2015. The company issued 4,000,000 shares at $18.00-$20.00 per share. WR Hambrecht + Co acted as the underwriter for the IPO.

How do I buy shares of XBiotech?

Shares of XBIT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XBIT) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners